1. Home
  2. TRAK vs PBYI Comparison

TRAK vs PBYI Comparison

Compare TRAK & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$12.25

Market Cap

245.1M

Sector

Technology

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$6.00

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
PBYI
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.1M
263.4M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
TRAK
PBYI
Price
$12.25
$6.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
96.1K
380.6K
Earning Date
02-11-2026
11-06-2025
Dividend Yield
0.65%
N/A
EPS Growth
19.98
59.87
EPS
0.36
0.74
Revenue
$23,136,391.00
$211,995,000.00
Revenue This Year
$8.29
N/A
Revenue Next Year
$24.17
N/A
P/E Ratio
$34.36
$7.99
Revenue Growth
11.05
N/A
52 Week Low
$11.98
$2.58
52 Week High
$23.72
$6.27

Technical Indicators

Market Signals
Indicator
TRAK
PBYI
Relative Strength Index (RSI) 30.98 62.57
Support Level $12.91 $5.81
Resistance Level $13.48 $6.27
Average True Range (ATR) 0.53 0.22
MACD -0.05 0.02
Stochastic Oscillator 16.32 63.29

Price Performance

Historical Comparison
TRAK
PBYI

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: